Has COVID-19 stopped or delayed your clinical trials? ELPRO can help.

Easy and Secure Medication Monitoring
for Clinical Trials at Home

While global research into potential COVID-19 vaccines and treatments is speeding along, the pandemic has slowed or stopped clinical trials for the virus as well as other diseases. Clinical trials demand patient travel, doctors, and clinical space — all are challenged due to the rapid spread of Covid-19. 

Since March nearly 100 companies have reported disruptions
to clinical trials due to COVID-19. Medical centers around the world
have focused their precious resources on treating those that are infected.

Numerous Phase 2 and 3 clinical trials are currently in jeopardy, putting thousands of patients at risk of not receiving further treatments. When these take longer than expected, how can clinical professionals push current pending Phase 1 trials further without losing focus and control on safety, quality and compliancy?

Moving from a "hospital-centric" to a "patient-centric" trial means organizational change
and discussions with authorities about your renewed supply chain and compliancy.